Milestone Scientific (NYSE:MLSS – Get Free Report) and electroCore (NASDAQ:ECOR – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and profitability.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Milestone Scientific and electroCore, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Milestone Scientific | 0 | 0 | 1 | 0 | 3.00 |
| electroCore | 1 | 1 | 1 | 0 | 2.00 |
Milestone Scientific presently has a consensus price target of $1.00, suggesting a potential upside of 214.47%. electroCore has a consensus price target of $18.00, suggesting a potential upside of 131.36%. Given Milestone Scientific’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Milestone Scientific is more favorable than electroCore.
Valuation & Earnings
This table compares Milestone Scientific and electroCore”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Milestone Scientific | $9.42 million | 3.06 | -$6.93 million | ($0.04) | -7.95 |
| electroCore | $36.97 million | 1.90 | -$13.97 million | ($1.66) | -4.69 |
Milestone Scientific has higher earnings, but lower revenue than electroCore. Milestone Scientific is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Milestone Scientific and electroCore’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Milestone Scientific | -52.01% | -60.26% | -40.23% |
| electroCore | -39.96% | N/A | -81.35% |
Volatility and Risk
Milestone Scientific has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500. Comparatively, electroCore has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500.
Insider and Institutional Ownership
5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 9.2% of Milestone Scientific shares are owned by insiders. Comparatively, 7.8% of electroCore shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Milestone Scientific beats electroCore on 9 of the 13 factors compared between the two stocks.
About Milestone Scientific
Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
About electroCore
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
